Kraig Biocraft Laboratories, Inc. (KBLB) financial news, and detailed stock charts
Kraig Biocraft Laboratories, Inc. (KBLB/KBLB.OB) Stock Summary:
Kraig Biocraft Laboratories, Inc. focuses on the development of protein based fiber using recombinant DNA technology for commercial applications in the textile and specialty fiber industries. Its products are used in military and police departments; industrial applications, including critical cables and abrasion/impact resistant components; and consumer applications. These fibers are also employed in safety equipment, and high strength composite materials for the aero-space industry. The company was founded in 2006 and is based in Lansing, Michigan.1 Employees
Founded in 2006
KRAIG BIOCRAFT LABORATORIES (KBLB:OTC Bulletin Board Market)
LAST $0.01 USD
CHANGE TODAY 0.00 0.00%
VOLUME 4.0K
As of 8:10 PM 01/27/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of KRAIG BIOCRAFT LABORATORIES (KBLB)
|
OPEN
$0.01
|
PREVIOUS CLOSE
$0.01
|
|
|
DAY HIGH
$0.01
|
DAY LOW
$0.01
|
|
|
52 WEEK HIGH
05/28/09 - $0.15
|
52 WEEK LOW
11/23/09 - $0.0090
|
|
|
MARKET CAP
6.4M
|
AVERAGE VOLUME 10 D
71.5K
|
|
|
EPS TTM
--
|
SHARES OUTSTANDING
513.6M
|
|
|
KBLB Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for KRAIG BIOCRAFT LABORATORIES (KBLB)
Kraig Biocraft Laboratories, Inc. announced delayed 10-Q filing
11/16/2009
On 11/16/2009, Kraig Biocraft Laboratories, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Kraig Biocraft Laboratories Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2009
08/17/2009
Kraig Biocraft Laboratories Inc. reported earnings results for the second quarter ended June 30, 2009. For the quarter, the company reported net loss was $148,933, down $92,458 for the same quarter the previous year (2008).
Kraig Biocraft Laboratories, Inc. announced delayed 10-Q filing
05/18/2009
On 05/18/2009, Kraig Biocraft Laboratories, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Kraig Biocraft Laboratories, Inc. financial resources
KBLB Competitors
| Company | Last | Change | |
| No competitor information is available for KBLB. | |||
| Market data is delayed at least 15 minutes. | |||
Industry Analysis
| Valuation | KBLB | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
|
KBLB |
||
More Recent Financial News About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. Gears Up to Double the Number of Genetic Insertions Performed
2009-11-30 04:14:07
Quote: In 2007 Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time the Company has been a proud sponsor of scientific research and development within the university.
www.KraigLabs.com
This press release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act o...Read article
Kraig Biocraft Laboratories, Inc. Successfully Creates Genetic Constructs for Several Unique Fusion Silk Proteins
2009-11-30 04:14:07
Quote: In 2007, Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time, the Company has been a proud sponsor of scientific research and development within the university.
www.KraigLabs.com.
http://www.globenewswire.com/newsroom/prs/?pkgid=4817
This press release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as ...Read article
SectorWatch.biz: Paving the Way for Spider Silk
2009-11-30 04:14:06
Quote: perhaps until now.
Enter Kraig Biocraft Laboratories, which is developing a way of inserting spider silk DNA directly into silkworms allowing the silkworms to produce the proteins for spider silk. This genetically-engineered spider silk could conceivably dominate the high performance fiber market, a market potentially worth billions.
http://www.usequitynews.com/news/the-new-silk.html
SectorWatch.biz is powered by Market Pathways, a leader in the representation of smallcap equities for nearly t...Read article
Kraig Biocraft Laboratories, Inc. Issues Stock Dividend
2009-11-30 04:14:06
Quote: In 2007 Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time the Company has been a proud sponsor of scientific research and development within the university.
www.KraigLabs.com
http://www.globenewswire.com/newsroom/prs/?pkgid=4817
This press release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as ame...Read article
SectorWatch.biz: The Super-Fiber Revolution
2009-11-30 04:14:05
Quote: Spider silk can also stretch about 30% longer than its original length without breaking, making its threads extremely resilient.
Kraig Biocraft Laboratories is developing a way of inserting spider silk DNA directly into silkworms allowing silkworms to produce the proteins for spider silk. Kraig is working in cooperation with University of Notre Dame scientists and laboratories to create new polymers with potentially broad applications for consumers and industry in the $92 billion marketplace fo...Read article
KRAIG BIOCRAFT LABORATORIES, INC Files SEC form 10-Q/A, Quarterly Report
2009-11-30 04:14:04
Quote: Accordingly, in conjunction with reading this
amendment to the Original Filing, you should also read all other filings we have
made with the Securities and Exchange Commission since August 13, 2009.
KRAIG BIOCRAFT LABORATORIES, INC.
FORM 10-QJune 30, 2009INDEX
PART I-- FINANCIAL INFORMATION
Item 1.Financial Statements1
Item 2.Management's Discussion and Analysis of Financial Condition 17
Item 3Quantitative and Qualitative Disclosures About Market Risk19
Item 4T. Control and Procedures19
...Read article
KRAIG BIOCRAFT LABORATORIES, INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review
2009-11-30 04:14:04
Quote: Item 4.02, Non-Reliance on Previously Issued Financial Statements or a Related
Audit Report or Completed Interim Review
On November 20, 2009, Kim Thompson, President and Chief Executive Officer of
Kraig Biocraft Laboratories, Inc.,(the "Company"), concluded that the previously
issued financial statements for the period ended June 30, 2009 should no longer
be relied upon because the Company did not account for a derivative liability
associated with the CEO's employment agreement. Spe...Read article
Would you like to leave a comment about Kraig Biocraft Laboratories, Inc. KBLB/KBLB.OB
Find out what social network information about Kraig Biocraft Laboratories, Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Kraig Biocraft Laboratories, Inc.'s Stock there is more great Microcap and Stock Market information available at Realpennies.com